TIMD4 and lung cancer: As expected, siRNA targeting OPA1 also reversed the promotion of mitochondrial activity induced by TIM-4 overexpression in lung cancer cells, including the increase in mitochondrial membrane potential (Fig. S2G, H), and the differences in the numbers of damaged and healthy mitochondria (Fig. S2I–L).